Product Images Yasmin

This appears to be a chart displaying the risk of blood clots for women based on their pregnancy status and use of CoC (contraceptive pills) over a period of 10,000 women years. The chart shows that non-pregnant non-COC users have the lowest risk of blood clots, while postpartum women (up to 12 weeks after delivery) and CoC users have a higher risk. The data is based on reference studies and actual pregnancy duration.*

Drospirenone Ethinyl estradiol is a combination of two female hormones used for oral contraception.*

This text describes different methods of birth control and their effectiveness. It provides statistics on the number of pregnancies per 100 women for various levels of contraception. The text mentions several methods such as pills, injections, devices, and sterilization. It also mentions choices like no sex, withdrawal, and the use of spermicide.*

This appears to be a chart or graph showing the number of women with a blood clot out of 10,000 women years (WY), for different categories including non-COC users, pregnant women and postpartum women (up to 12 weeks). The data for pregnancy is based on actual duration of pregnancy in reference studies and assumes a pregnancy duration of nine months. The chart also indicates that the rate of blood clotting is 7 to 27 per 10,000 WY for pregnant women. There is also mention of non-pregnant and non-COC (contraceptive oral contraceptive) users but no additional information is provided.*

This text is a prescription for Yasmin birth control pills. It provides instructions for taking one tablet daily and includes the product's NDC number, batch, and expiration date. The text also warns against transferring the drug to anyone other than the patient it was prescribed for due to federal law.*